This then implied a possibility of different mechanisms that we can attribute to the increase in concentration of tau proteins, accounting for quantitative inhomogeneity between phosphorylated and un-phosphorylated tau proteins in the blood of AD patients. This evidence concerns the gene MAPT and Alzheimer disease.